Uloric
Formulated to alleviate chronic high uric acid and intended to support patients with gout.
Strengths: 40 · 80mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Adenuric
- Therapeutic class
Xanthine Oxidase Inhibitor
- Pharmacological class
Xanthine Oxidase Inhibitor
- Precautions and warnings
monitor liver function; watch for cardiac symptoms
- Minor side effects
nausea; headache
- Moderate side effects
gout flares; elevated liver enzymes
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Takeda
- Onset Time
varies
- Duration
24 hours
- Storage instructions
Store below 30°C.
- Drug interactions
Azathioprine; Mercaptopurine
- Age restrictions
Not for paediatric use.
Contraindications
hypersensitivity to febuxostat; ischaemic heart disease; congestive heart failure
Serious side effects
serious cardiovascular events — requires immediate medical attention; severe skin reactions — requires immediate medical attention
Patient summary
Formulated to alleviate chronic high uric acid and intended to support patients with gout.
Mechanism of action
Uloric works as a potent xanthine oxidase inhibitor, reducing the production of uric acid in the body, thereby preventing the formation of urate crystals in joints.
Pregnancy and breastfeeding
Pregnancy: Use with caution if benefit outweighs risk. Breastfeeding: Advised to avoid.
Uloric
Formulated to alleviate chronic high uric acid and intended to support patients with gout.
Editorial Notes
- Active ingredient(s): Febuxostat
- Listed indication(s): Hyperuricaemia, Gout
Usually available as
- 120 tablets - 40 mg1456-40-mg-17505
- 90 tablets - 80 mg1456-80-mg-17509